Home » Stocks » PDEX

Pro-Dex, Inc. (PDEX)

Stock Price: $30.03 USD 1.33 (4.63%)
Updated Jan 19, 2021 4:00 PM EST - Market closed
Market Cap 115.94M
Revenue (ttm) 36.18M
Net Income (ttm) 6.27M
Shares Out 3.85M
EPS (ttm) 1.55
PE Ratio 19.34
Forward PE 20.66
Dividend n/a
Dividend Yield n/a
Trading Day January 19
Last Price $30.03
Previous Close $28.70
Change ($) 1.33
Change (%) 4.63%
Day's Open 29.10
Day's Range 29.13 - 30.35
Day's Volume 20,601
52-Week Range 14.04 - 42.60


Hide News
Newsfile Corp - 2 months ago

Phoenix, Arizona--(Newsfile Corp. - November 11, 2020) - The Stock Day Podcast welcomed Pro-Dex, Inc. (NASDAQ: PDEX) ("the Company"), a company that specializes in the design, development, and...

GuruFocus - 3 months ago

According to the GuruFocus All-in-One Screener, a Premium feature, as of Oct. 8, the following companies are trading below their Peter Lynch fair value with wide margins of safety and have had...

Other stocks mentioned: BELFB, EML, FSTR, PERI
GuruFocus - 4 months ago

Growth-focused investors may be interested in the following stocks since their price-earnings ratios still trade below 20 and their trailing 12-month earnings per share have grown significantl...

Other stocks mentioned: CORT, LL

About PDEX

Pro-Dex designs, develops, and manufactures powered surgical instruments for medical device original equipment manufacturers worldwide. The company offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and maxocranial facial markets. It also provides engineering, quality, and regulatory consulting services; and manufactures and sells rotary air motors to various industries. The company was founded in 1978 and is headquartered in Irvine, California.

Medical Instruments & Supplies
Richard Van Kirk
Stock Exchange
Ticker Symbol
Full Company Profile

Financial Performance

In 2020, Pro-Dex's revenue was $34.83 million, an increase of 28.20% compared to the previous year's $27.17 million. Earnings were $6.11 million, an increase of 47.35%.

Financial Statements

Analyst Forecasts

According to one analyst, the rating for Pro-Dex stock is "Strong Buy" and the 12-month stock price forecast is 40.00.

Price Target
Analyst Consensus: Strong Buy